Paula Trahan Rieger, RN, MSN, CAE, FAAN is the Chief Executive Officer of the Oncology Nursing Society, based in Pittsburgh, PA. Prior to that she served as the Director of International Affairs for the American Society of Clinical Oncology, based in Alexandria, VA. She worked at The University of Texas M.D. Anderson Cancer Center in Houston for twenty three years, working as a nurse practitioner in the Department of Clinical Cancer Prevention, Human Clinical Cancer Genetics Program providing cancer genetic counseling from 1996 - 2002. She has primarily worked in the field of medical oncology with an expertise in the fields of biotherapy and cancer genetics.
Ms. Rieger received her Master of Science in Nursing degree from The University of Texas Health Science Center in Houston after receiving her Bachelor of Science in Nursing degree from the University of California, Los Angeles. In addition, Ms. Rieger has a Bachelor of Science in Biology and has completed studies as a nurse practitioner at The University of Texas Health Science Center/Houston. She has been certified as an advanced oncology nurse by the Oncology Nursing Certification Corporation.
She has been active at both the local and national levels of the Oncology Nursing Society (ONS). She served on the ONS Board of Directors as Secretary and on the Oncology Nursing Foundation Board of Directors from 1995-1998. She completed a two-year term as President of the Oncology Nursing Society in April of 2002 and a two-year term as Immediate Past-President in 2004 where she served on the Nominating Committee. She also served as an Associate Editor for the Oncology Nursing Forum and was a co-editor of the Leadership & Professional Development column.
She has maintained continuous support of the nursing profession through publications, contributions as a research collaborator, and over 200 presentations at scientific and professional meetings on biotherapy, cancer genetics, symptom management and other cancer-related topics. She has edited four books on the subject of biotherapy and served as a consult in the production of numerous educational videotapes for both patients and health care professionals. In 1992, she was awarded the Schering/ONS Excellence in Biotherapy Award and in 1994 was a co-recipient of the ONS/CHIRON Therapeutics/Susan Baird Oncology Excellence in Writing Award. In 1993, she received the International Patient Education Council’s Outstanding Patient Educator Award. In 1997, Ms. Rieger (Co-Principal Investigator) was awarded an Oncology Nursing Foundation grant in the amount of $8500 for “Nurses’ Knowledge and Attitudes Regarding Genetics and Genetic Testing”. In 1997, she was inducted as a fellow in the American Academy of Nursing. In 1999 she was awarded the Oncology Nursing Society/Ortho Biotech Inc. FIRE Excellence Award for recognition of outstanding contribution to the management of patients with cancer-related fatigue.